- No more ‘old school’: How Duke Health is reimagining workforce development
- Why private practice dentistry needs a better model
- Chief nurses: Hospital finances improve with nursing investments
- Mississippi health system goes ‘all in’ on Epic with $115M investment
- CareQuest Innovation Partners, Kno2 collab on medical-dental data integration
- Ascension Wisconsin CEO to step down
- The hospitals, health systems cutting jobs in 2026
- The hospitals, health systems cutting jobs in 2026
- Nonprofit highlights rural opioid care strategies
- The 7 things on the table in the Mount Sinai-Anthem negotiations
- The 7 things on the table in the Mount Sinai-Anthem negotiations
- Wearables data predicts patient engagement: Mayo Clinic study
- Advocate plans largest US hospital drone delivery network
- Vitana Pediatric & Orthodontic Partners adds Florida practice
- Indiana system opens $21.7M outpatient center
- Trump administration targets medical school admissions: 4 notes
- EyeSouth Partners continues 2026 expansion with Louisiana practice
- RSV lingers in parts of US even as flu and COVID-19 recede
- Providence narrows operating loss to $486M in 2025
- A huge month for CMS policy
- What the Health? From KFF Health News: A Headless CDC
- GI is exploding with new tech—but how do patients feel about it?
- Maryland physician to pay $500K+ to settle false claims allegations
- Rhode Island oral surgeon launches Congressional campaign
- Premier Anesthesia, City of Hope Phoenix ink partnership
- 20 behavioral health leaders challenge industry assumptions
- What simulation training revealed about GI skills gaps
- Judge dismisses physician’s wrongful termination suit against staffing firm
- 3 California behavioral health centers to close amid funding shifts
- North Carolina practice to close after 40+ years
- St. Tammany opens outpatient cardiology center
- Indiana bars autism therapy provider from Medicaid billing: Wall Street Journal
- 6 dental practice openings to know
- UnitedHealth shareholder sues over proposal to include details on integration in annual proxy
- APRNs, PAs account for most antipsychotic prescriptions for Medicare Part D: Study
- Infosys to acquire Optimum Healthcare IT in $465M deal
- Oklahoma House passes bill expanding scope of dental assistants
- Dr. Nellie Kim-Weroha joins American Association of Orthodontists’ Board of Trustees
- California behavioral health agency to close 2 centers
- St. Luke’s CFO joins RCM company’s advisory board
- 52 DSOs to know: 2026
- 10 hospitals, health systems looking for CFOs
- DOJ alleges NewYork-Presbyterian forces payers into anticompetitive 'all-or-nothing' contracts
- 10 health system rating downgrades
- FDA Warns Biotech Firm Over Cancer Drug Anktiva Claims
- Bees and Hummingbirds May Be Consuming Small Amounts of Alcohol
- Two States Sue Cord Blood Company Over Misleading Claims
- North Star’s restructuring moves forward
- Illinois hospital pauses patient care amid payroll challenges
- What the Best-Performing Revenue Cycles Have in Common
- New WHO Guidance Aims To Speed Tuberculosis Testing
- As questions swirl around ATTR competition, Alnylam plots path to market leadership for Amvuttra
- Trump admin delays nomination for new CDC director past deadline
- Outspoken ACIP member steps down amid vaccine panel uncertainty: reports
- Egg-based drugmaker Neion Bio emerges from stealth to cook up multi-product biosimilar collab
- Genentech walks the walk in lupus as sponsor of annual awareness and fundraising event
- Study Reveals How Many Americans Consider Using a Gun
- Massive Study Finds Stress and Grief Don’t Cause Cancer
- Ultra-Processed Foods Harm Fertility In Both Men And Women, Studies Reveal
- Small Daily Habits Can Add Up To Better Heart Health
- Ritalin Might Protect ADHD Kids' Long-Term Mental Health, Study Finds
- Can You Drink Enough Fluids To Prevent Kidney Stones? Maybe Not, New Study Says
- Clasp, loan-linked hiring tool for employers, clinches $20M to expand amid federal loan caps
- Taking a GLP-1? Doctors Say Not To Forget About Movement and Mental Health
- OpenEvidence rolls out AI medical coding feature
- CDC’s Acting Chief Promises a Return to Stability in a Tumultuous Moment
- California peer-run behavioral health center to close amid funding shift
- Remarks at the Financial Stability Oversight Council Meeting
- ‘Integration only works if data lives in the same system’: How 5 systems are operationalizing behavioral health
- Medicaid work rules and enrollment losses: 6 notes
- Inside UHS’ playbook for responsible behavioral health growth
- Epic4 Specialty Partners adds Illinois practice
- The unsolved problems still plaguing dentistry
- American Dental Association adds mental health, GLP-1 prompts to patient forms
- RWJF: Between 5M and 10M people could lose Medicaid coverage in 2028 under work requirements
- Gen Z nurses prioritize schedule flexibility, need more manager interactions to avoid turnover
- How pharma marketers can capitalize on HCPs’ AI, social media and streaming habits
- Federal Officials Investigate States That Require Abortion Coverage
- Corcept's lead drug bounces back from FDA snub with different approval as Lifyorli in ovarian cancer
- Ionis slashes Tryngolza's price tag by 93% ahead of anticipated label expansion
- FDA approves Denali's Hunter syndrome drug, handing rare disease community a win
- Baby Walkers Sold on Amazon Recalled Over Fall Risk
- Want To Protect Your Brain? Science Says Exercise
- HelloFresh Pizza Recall Issued in 10 States Over Metal Risk
- Clinical Trials Have Too Much Data…That’s the Problem.
- Clinical Trials Have Too Much Data…That’s the Problem.
- CMS reveals new Medicaid model that supports coordination for children with complex needs
- Novartis sued by breast cancer patient over branded drug websites’ data-sharing practices
- Takeda targets $1.3B in cost savings in further restructuring
- Biogen pays $20M upfront to tap into Alteogen's subQ delivery tech
- 'Universal Donor' Blood Supplies Dangerously Low, Study Warns
- Why Stepping Outside May Help You Eat Better
- U.S. Medicine, Science Facing An Online Misinformation Siege, Poll Concludes
- Childhood Obesity Undercuts The American Dream For Some, Study Says
- Inclusive High Schools Benefit All Students, Not Just LGBTQ Teens
- Parental Loss Due to Drugs, Violence Raises Child Death Risk by 2,000%
- As Boehringer touts US launches, board chairman worries EU is 'falling further behind'
- The evolving state of exome and genome sequencing
- An Arm and a Leg: Steep Health Care Costs Steer Americans to Tough Decisions
- Demoralized CDC Workforce Reels From Year of Firings, Funding Cuts, and a Shooting
- Qualified Health locks in $125M in fresh funding to scale enterprise AI at health systems
- Misery Loves [Investment] Company?: Remarks at the 2026 Investment Company Institute Investment Management Conference
- Study: Nearly 1 in 5 pediatric hospital deaths involve sepsis
- As expansions come online, CDMO Hovione aims to meet industry's 'dual supply and sourcing' zeal: exec
- Opening Remarks at the Digital Asset Summit 2026
- CVS Caremark, FTC reach settlement in insulin pricing case
- UCB unveils plan to build $2B biologics plant near its US headquarters in Atlanta
- PeaceHealth sued over plans to tap out-of-state staffer ApolloMD for Oregon EDs
- New Lyme Disease Vaccine Shows Strong Results in Trial
- TrumpRx Adds Diabetes, COPD Drugs at Steep Discounts
- Highmark reports $175M net loss for 2025 as financial headwinds batter health plan
- Listen to the Latest ‘KFF Health News Minute’
- Abivax hires commercial chief from Takeda to infuse Entyvio expertise into IBD launch prep
- ImmunityBio hit with FDA warning letter over Anktiva promotions in TV ad, podcast episode
- Alcohol Prep Pads Recalled Over Bacteria Risk, Cardinal Health Says
- Fewer patients traveled for abortions in 2025 as telehealth care increased, report finds
- Cologuard campaign reunites ‘Full House’ stars to give ‘The Talk’ about colon cancer screening
- Lilly to remove certain insulin products from European markets by 2027
- Karyopharm, looking to jump-start Xpovio, reports mixed results in myelofibrosis
- Study Warns Fluoride Bans May Raise Tooth Decay in Children
- WuXi Bio's record number of new projects in 2025 leaned heavily on US clients
- “Me engañaron”: agentes encadenan a un padre que había ido al ICE a reunirse con sus hijos
- Gilead inks Manta pact to dive deeper into cancer patient support
- Cheap Children's Clothing Tainted With Lead, Study Says
- Insulin Prices Fell For Medicare Patients Under Biden-Era Caps, Study Finds
- New Fathers Face Mental Health Challenges, Study Finds
- Your Choice Of Booze Influences Your Risk Of Death, Study Says
- AI Gets a 'D' When Judging Scientific, Medical Claims
- New Online Tool Helps Parkinson's Patients Weigh Brain Implant Decision
- AI chatbot use for health information up 16% from 2024: Rock Health survey
- ‘They Tricked Me’: A Father Was Chained After He Went to ICE To Reunite With His Kids
- Wilmington PharmaTech commits $50M to US API expansion
- Strides recalls nearly 90K bottles of children's ibuprofen after contamination complaints
- Trump administration unveils national policy framework for AI as it moves to override state laws
- Breast Cancer Locator System Submitted for De Novo 510(k) by Cairn Surgical
- Breast Cancer Locator System Submitted for De Novo 510(k) by Cairn Surgical
- 17 spine surgery firsts in Q1
- 17 spine surgery firsts in Q1
- Cencora acquiring EyeSouth Partners' retina business for $1.1B
- Aunque tengas seguro dental, la factura puede ser muy alta
- A look at how Optum Rx is using AI to address pharmacy fraud, waste and abuse
- Nursing Homes Accused of False Diagnoses To Hide Drug Use
- FDA Approves Higher-Dose Wegovy To Help People Lose More Weight
- Teens Often Pressured To Send Sexual Photos by Someone They Know, Study Finds
- Nearly 90,000 Bottles of Children’s Ibuprofen Recalled Nationwide
- Algunos adultos de mediana edad deciden posponer la atención médica hasta tener Medicare
- Rural Residents Have Highest Cancer Death Rates, Researchers Say
- Your Bank Account Might Show How Well Your Brain Will Age, Researchers Say
- Insurance Lapses Play Havoc With Diabetes Management, Study Shows
- Psychedelics Aren't Better Than Antidepressants In Treating Depression, Review Concludes
The once and future President Trump has nominated Dr. Martin Adel Makary to head the Food and Drug Administration. Stanley Goldfarb, an emeritus professor of medicine at the University of Pennsylvania, has just posted a review of Dr. Makary's latest book: Blind Spots:When Medicine Gets It Wrong, and What It Means for Our Health. The review gives you some insight into Dr. Makary's thoughts on health care in America:
https://freebeacon.com/culture/in-search-of-a-second-opinion/
In Search of a Second Opinion
REVIEW: ‘Blind Spots: When Medicine Gets It Wrong, and What It Means for Our Health’ by Marty Makary
By Stanley Goldfarb - November 24, 2024When patients turn to professional societies like the AMA or the American College of Physicians or the American Association of Pediatrics for vital health information, one might expect that the information is based on publications in prestigious medical journals of carefully designed and meticulously interpreted studies. Dr. Marty Makary, in his book Blind Spots, shows how wrong these assumptions can be.
Makary is a frequent commentator on health-related topics. He is a surgeon and surgical oncologist at Johns Hopkins Hospital. Blind Spots consists of several examples where the medical establishment has perpetuated a myth often based on a single academic’s opinion that became ingrained in the culture as "truth" despite the flimsiest of evidence. Using examples like avoiding exposure to peanuts in infants, producing an epidemic of peanut allergy, or denying the benefits of hormone replacement therapy in perimenopausal women, resulting in premature deaths and suboptimal health outcomes, Makary proves his case against groupthink in medicine. He goes on to rail against the overuse of antibiotics because of their potential for altering the microbial composition in the GI tract. Recent research shows that this effect of antibiotics may contribute to serious complications, including risks for cancer and cardiovascular disease.
Another section recounts the saga of the treatment of ulcers of the upper GI tract. Ulcer disease was treated as a neuropsychiatric disorder that required behavioral modification and buffering stomach acid to prevent recurrences. The evidence that a particular bacterium caused stomach ulcers was known for several years, but the medical establishment resisted this insight simply because it flew against conventional wisdom. Eventually, Dr. Barry Marshall won the Nobel Prize in medicine for the discovery. He had to induce his own ulcer disease by ingesting the bacteria that he identified to finally convince the skeptics.
Makary also visits the controversy about so-called gender-affirming care for children. This treatment involves drugs that prevent children with confusion about their sexuality from experiencing a normal puberty, administers sex characteristic-altering hormones, and even life-altering surgical procedures like mastectomies. He quotes some of the most thoughtful critics of these procedures, such as Lisa Littman, who first identified the phenomenon of the rapid onset of gender dysphoria when teenage girls first encounter the earliest phases of puberty. Despite overwhelming evidence that she was correct in her idea that these children had a temporary form of juvenile angst, she was effectively "canceled" because the concept undermined the theory of an underlying biological basis for the psychological disorder.
Gender-affirming care is yet another idea that falls into the category of dangerous treatments accepted by the medical establishment despite ongoing proof that it harms many children. Sadly, almost every major American medical society supports gender-affirming care for these troubled children, while several European nations have examined their own experience with this therapy and the published medical evidence with an open mind and now severely restrict its implementation.
Readers will find this book interesting if they have not had much of a background in biomedical science. It is clear, concise, and well-documented. They may ask a few more questions at their yearly checkup, and that is a good thing.
Why do these wrongheaded approaches to medical care exist, and what can be done to prevent their perpetuation? Makary describes the phenomenon of maintaining a closed mind in the face of contravening data but never quite gets to the originating cause of this attitude in the medical establishment. He does make a strong case for the benefit of classical liberal principles, such as freedom of speech and willingness to confront hierarchies as antidotes. But at a time when conformity and groupthink seem to have taken hold of the most recent generations of physicians, Makary nonetheless praises the current young generation as including vigorous disruptors who will challenge the medical status quo. But has he watched the cult-like recitations of new medical students at their white coat ceremonies about land acknowledgments to indigenous people and obeisance to the oppressor/oppressed paradigm of "systemic racism"? They don’t seem likely to challenge anything.
The unwillingness to have an open mind when examining controversial topics or confronting new information suggests a deeper problem. The problem is, in large part, the culture of medical education. More and more, physicians are taught and regurgitate the "facts." Medicine has increasingly focused on doing rather than knowing. The monetary rewards are skewed toward performing procedures and tests. Understanding basic disease mechanisms or evaluating the quality of medical studies are less valued. This is not a new problem, and Makary cites examples of physicians ignoring best practices or new knowledge in favor of traditional approaches going back centuries. It is easy to understand how this attitude predominated in the era when medical science was primitive, and all that existed was opinion. But modern medical science allows physicians to approach clinical problems with a deep understanding of the mechanisms of disease and underlying biomedical science. Despite this, the failure to improve the closed-mindedness is ongoing. The problem has become more acute given the recent trend in training medical students to be social justice warriors rather than rigorous clinical scientists.
Medical students now learn almost exclusively through taking practice exams and studying the answers to the multiple-choice questions that make up the exams. It is virtually unheard of for students to be assigned textbooks or even specific articles in the medical literature and then asked to interpret the information. They chafe when presented with basic science information if its clinical relevance is not immediately obvious. Yet such knowledge is crucial to good medicine.
To develop independent thinking among physicians, the medical curriculum should develop critical thinking skills about biomedical topics, and students recruited to become physicians should be those who embrace such an approach. Instead, students are increasingly chosen based on their agreement with theories of "systemic racism" and "social determinants of health" rather than their potential to become clinical scientists.
Makary believes that among the current crop of trainees are those who will disrupt the modes of thinking that produce the wrongheaded outcomes he describes. I fear he is wrong in his prescription. I think a more active intervention is needed. Undergraduate and graduate medical education need a reform agenda. Deep learning on experimental design, data interpretation, critical reading of the medical literature, and understanding the philosophy of science should replace the many hours currently spent trying to turn young physicians into social workers.
Blind Spots: When Medicine Gets It Wrong, and What It Means for Our Health
by Marty Makary
Bloomsbury Publishing, 288 pp., $28.99
Stanley Goldfarb is an emeritus professor of medicine at the University of Pennsylvania and father of Washington Free Beacon chairman Michael Goldfarb.
In short - med students need training in how to think, instead of what to think.
I couldn't agree more! Cookie-cutter medicine is letting patients everywhere fall through the cracks.
Another fascinating take on Dr. Makary comes from his previous employer and my frequent source in this Forum for Healthcare Headlines.
https://www.medpagetoday.com/washington-watch/fdageneral/113078
Trump's FDA Pick Is MedPage Today's Former Top Editor
— Marty Makary has made a name for himself challenging the medical establishment
President-elect Donald Trump has chosen Marty Makary, MD, MPH, to run the FDA.
Makary served as the editor-in-chief of MedPage Today from January 2020 through the end of 2021.
"FDA has lost the trust of Americans, and has lost sight of its primary goal as a regulator. The Agency needs Dr. Marty Makary, a Highly Respected Johns Hopkins Surgical Oncologist and Health Policy Expert, to course-correct and refocus the Agency," Trump said on Friday, in announcing the nomination on Truth Social.
"He will work under the leadership of Robert F. Kennedy Jr. to, among other things, properly evaluate harmful chemicals poisoning our Nation's food supply and drugs and biologics being given to our Nation's youth, so that we can finally address the Childhood Chronic Disease Epidemic," Trump added.
Trump also announced the nominations of Dave Weldon, MD, for CDC Director and Janette Nesheiwat, MD, for U.S. Surgeon General.
Makary has written three books on medicine and healthcare: Blind Spots, The Price We Pay, and Unaccountable, the last of which was turned into a TV series called "The Resident." A theme of all three books is challenging the status quo in medicine, questioning the evidence base for certain treatments and established clinical practices. Among his top issues, Makary has taken on the high costs of healthcare and medicine's penchant for overtreatment. He also authored Mama Maggie, a book about a woman who aids the poor people of Egypt's slums.
Early in the COVID-19 pandemic, Makary espoused some views that were in opposition to mainstream medicine, including championing the power of natural immunity, challenging vaccine mandates, and questioning the need for COVID vaccines in children. Makary famously predicted in February 2021 that the U.S. would have "herd immunity by April" 2021.
In 2023, Makary testified before Congress that a lab leak origin of SARS-CoV-2 from the Wuhan Institute of Virology in China was a "no-brainer."
More recently, he has reverted to speaking out against the core business-of-healthcare issues that initially sparked his rise to fame, including how hospitals that make profits should pay taxes, and exposing how certain Medicare policies enable hospital and health system monopolies.
Makary completed his surgical residency at Georgetown University Hospital in Washington, D.C., after attending medical school at Thomas Jefferson University in Philadelphia. He received his Master of Public Health degree from Harvard University. In 2018 he was elected to the National Academy of Medicine.
At FDA, Makary would be in charge of the agency's annual budget of $7 billion, and he would report to Kennedy, Trump's pick for HHS secretary, if confirmed by the Senate.
Late last month, Kennedy lashed out at the FDA in a post on X: "FDA's war on public health is about to end. This includes its aggressive suppression of psychedelics, peptides, stem cells, raw milk, hyperbaric therapies, chelating compounds, ivermectin, hydroxychloroquine, vitamins, clean foods, sunshine, exercise, nutraceuticals, and anything else that advances human health and can't be patented by Pharma. If you work for the FDA and are part of this corrupt system, I have two messages for you: 1. Preserve your records, and 2. Pack your bags."
Outgoing FDA Commissioner Robert Califf, MD, has fought against medical misinformation, and pushed for improvements in food safety and inspections. He recently said that under a Trump administration, FDA's ability to hire and retain skilled employees could be in jeopardy, given Kennedy's hostility to civil servants.
Dr. Martin Adel Makary is now the Commissioner of the Food and Drug Administration:
https://thehill.com/homenews/administration/5214293-senate-confirms-marty-makary-fda/
Senate confirms Marty Makary to lead FDA
By Nathaniel Weixel - March 25, 2025The Senate on Tuesday night confirmed Marty Makary to be the Food and Drug Administration commissioner.
Makary was easily confirmed by a 56-44 vote, picking up three Democrats.
Democratic Sens. Dick Durbin (Ill.) Maggie Hassan (N.H.) and Jeanne Shaheen (N.H.) voted with all Republicans to confirm Makary.
A Johns Hopkins surgeon, Makary will take over an agency hammered by workforce cuts imposed by Elon Musk’s Department of Government Efficiency.
He will also have to navigate politically tricky decisions on access to the abortion medication mifepristone, as well as about vaccine policy under Health and Human Services Secretary Robert F. Kennedy Jr, a prominent vaccine skeptic.
Democrats hammered Makary during his confirmation hearing on recent moves by the Trump administration to cut FDA staff and pressed him on plans to exercise his authority over mifepristone.
GOP senators urged him to curb access, while Democrats pressed him to keep the current policies in place.
Makary tread carefully in his responses, saying he had no preconceived notions about the drugs and would “take a solid, hard look at the data” about mifepristone’s safety.
Makary was a critic of federal COVID-19 mitigation policies and frequently appeared on Fox News during the pandemic.
Makary during his hearing largely said he supported the benefits of vaccines, even as he was being pressed about the recent cancellation of agency advisory panels.
“Vaccines save lives, and I do believe that any child who dies of a vaccine-preventable illness is a tragedy in the modern era,” he said.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.

















